India’s Biggest Drugmaker Plans to Start Developing Its Own Medicines
Dilip Shanghvi, chairman and founder of Sun Pharmaceutical Industries Ltd., poses for a photograph in Mumbai. (Photographer: Kanishka Sonthalia/Bloomberg)

India’s Biggest Drugmaker Plans to Start Developing Its Own Medicines

(Bloomberg Businessweek) -- You’d be hard-pressed to find someone who’s lost more during the recent upheaval in the generic drug business than Dilip Shanghvi: He forfeited $17 billion to be precis...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.